Category: News & Events

CVIA Volume 6 Issue 3 Published

The journal Cardiovascular Innovations and Applications (CVIA) has just published the third issue of Volume 6. This issue brings together important research from authors in China and the United States.

Papers in the issue are as follows.

REVIEW

Guoshuang Feng, Guoyou Qin, Tao Zhang, Zheng Chen and Yang Zhao

Common Statistical Methods and Reporting of Results in Medical Research

(DOI 10.15212/CVIA.2022.0001)

ORIGINAL ARTICLE

Rong-Xue Xiao, Xu Wang, Jun-Qing Gao and Zong-Jun Liu

A Case Summary of the Application of a Drug-Eluting Stent Combined with a Drug-Coated Balloon

in Left Main Coronary Artery Disease (DOI 10.15212/CVIA.2021.0027)

RESEARCH PAPERS

Hui Yang, Pu Zou, Yuhu He, Lingzhi Huang, Xinmin Zhou, Liming Liu, Zhenjiang Liu and Shenghua Zhou

Risk Factors for Prognosis after the Maze IV Procedure in Patients with Atrial Fibrillation

Undergoing Valve Surgery (DOI 10.15212/CVIA.2021.0026)

Yang Liu, Xunxun Feng, Jiaqi Yang, Tienan Sun, Guangyao Zhai, Qianyun Guo and Yujie Zhou

Prognostic Significance of HbA_1c Level in Asian Patients with Prediabetes and Coronary Artery Disease (DOI 10.15212/CVIA.2021.0029)

Xiaoling Ji, Shuqi Jin, Yuxia Wang, Yumiao Chen and Jing Zhang

Visfatin and 25-Hydroxyvitamin D3 Levels Affect Coronary Collateral Circulation Development in Patients with Chronic Coronary Total Occlusion (DOI 10.15212/CVIA.2021.0032)

Jia-Min Li, Wen-Yuan Ding, Fei Zheng, Yan-ying Jia, Li-Li Wang, Xin-Yi Wei, Ming-Ming Zhang, Cuihua Li and Guo-Hua Li

Effects of Tirofiban and Nicorandil on Effective Reperfusion and the Levels of IL-4 and sICAM-1 After PCI for Chronic Coronary Total Occlusion (DOI 10.15212/CVIA.2021.0033)

Boda Zhou, Yajun Xue, Jie Zhou, Shenjie Sun, Tingting Lv, Ou Zhang, Yu Geng, Guobin Miao and Ping Zhang

Fasting Blood Glucose but not TMAO is Associated with In-Stent Restenosis in Patients with Acute

Coronary Syndrome (DOI 10.15212/CVIA.2021.0034)

CASE REPORT

Oliver Abela, Michael Schoeller, Parker Williams, Charles Lambert and Marc Bloom

Valve-in-Valve Transcatheter Aortic Valve Replacement in a High-Risk Patient with a Biocor Bioprosthesis and a Flail Prosthetic Valve Leaflet (DOI 10.15212/CVIA.2021.0031)

Richard Conti, MD, MACC, Dr HC, FCP(SA), FESC, FAHA

Feb 24, 2022

It is with great sadness that we announce the passing of esteemed cardiovascular researcher and educator, and Editor in Chief of Cardiovascular Innovations and Applications, C. Richard Conti. Dr Conti has been deeply instrumental to the development of the journal since its launch in 2015; the Editorial Board and Publisher will greatly miss his enthusiasm and passion for cardiology research.

We extend our condolences to Dr Conti’s family, in particular to Editorial Board Member, Dr Jamie B. Conti, and to his friends and colleagues.

Dr. Conti’s honored career as a physician, researcher, teacher, administrator and prolific writer and editor spanned six decades. Born in Allentown, Pennsylvania in 1934, Dr. Conti grew up in Bethlehem and graduated from Lehigh University in 1956 and from the Johns Hopkins School of Medicine in 1960 as a member of the Alpha Omega Alpha Honor Society. He trained in internal medicine with the Osler Medical Service of The Johns Hopkins Hospital and completed a fellowship in cardiology at the same institution. Dr. Conti’s training was interrupted for two years when he served in the U.S. Army from 1962 to 1964. He was named chief resident of the Osler Medical Service in 1967, and in 1968, he joined the Johns Hopkins faculty as an assistant professor of medicine, rising to associate professor and medical director of the cardiac catherization laboratory before leaving for the University of Florida.

He served as president of the American College of Cardiology from 1989 to 1990, and was an elected member of the American Clinical and Climatological Association, the Association of University Cardiologists, and the Association of Professors in Cardiology. In 1991, Dr. Conti received an honorary fellowship from the College of Medicine of South Africa (FCP-SA), and in 1996, he was elected to the Johns Hopkins University Society of Scholars. He was awarded the Gifted Teacher Award from the Florida Chapter of the American College of Cardiology in 1999, and from the American College of Cardiology in 2002. In June 2000, he received a “Docteur Honoris Causa” from the University of Marseilles, and in 2004, he was named China Honorary Chair of the Great Wall International Congress of Cardiology (GW-ICC), Beijing.

Dr. Conti had a passion for teaching, and he shared his knowledge through his work as a writer and editor. He served as editor-in-chief for Educational Program Highlights of the American College of Cardiology for 14 years, for Clinical Cardiology for 13 years and for American College of Cardiology Extended Learning for 10 years. He was an editorial board member for the American Journal of Cardiology, the Journal of the American College of Cardiology, the European Heart Journal and numerous others. He authored or co-authored more than 700 scientific papers, book chapters and abstracts, and edited six books and wrote two.

CVIA Volume 6 Issue 2 Published

The journal Cardiovascular Innovations and Applications (CVIA) has just published the second issue of Volume 6. This issue brings together important research from authors in Egypt, Canada and China.

Papers in the issue are as follows.

RESEARCH PAPERS

Barriers to the Implementation of Primary PCI in the Management of STEMI in Egypt

Sameh Shaheen, Ayman Helal, Islam Anan

DOI: 10.15212/CVIA.2021.0017

Comparison of 5F Microtube-Irrigated Ablation Catheter and General Ablation Catheter in the Treatment of Resistant Hypertension with Renal Denervation

Jun-Qing Gao, Hong Zhang, Ling-Yan Li, Xu Wang, Jian Ye, Zong-Jun Liu

DOI: 10.15212/CVIA.2021.0023

Main Renal Artery plus Branch Ablation in the Treatment of Resistant Hypertension with Renal Denervation

Tian-Jiao Lyu, Ling-Yan Li, Xu Wang, Jian Ye, Jun-Qing Gao and Zong-Jun Liu

DOI: 10.15212/CVIA.2021.0024

Clinical Significance of Angiographically Detectable Neovascularity in Patients with Cardiac Myxomas

Xiaofan Peng, Yichao Xiao, Yanan Guo, Zhaowei Zhu, Liyan Liao, Xiaobo Liao, Xinqun Hu, Zhenfei Fang, Xuping Li, Shenghua Zhou

DOI: 10.15212/CVIA.2021.0025

CASE REPORTS

A case report of radiofrequency ablation of typical atrial flutter combined with atrial tachycardia

Chen Chun-hui, Ning Li-ye

DOI: 10.15212/CVIA.2021.0022

ST segment depression in I and aVL: artefactual or pathophysiological findings? Sharen Lee, Gary Tse, Xin Wang, Adrian Baranchuk, Tong Liu

DOI: 10.15212/CVIA.2021.0013

32nd Great Wall International Cardiology Conference (GW-ICC)

32nd Great Wall International Cardiology Conference (GW-ICC) and Asian Heart Society Congress 2021 Abstracts Publish in Cardiovascular Innovations and Applications

Cardiovascular Innovations and Applications (CVIA), in its role as the official journal of the Great Wall International Cardiology Conference (GW-ICC), has published selected abstracts from the 32^nd session, held virtually, October 27 – 31, 2021, in its latest publication volume 6, supplement 1.

The abstracts are now available online at https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2021.0030

Co-Editors-in-Chief of CVIA, C. Richard Conti, past president of the American College of Cardiology, and Jianzeng Dong, are delighted to be publishing the abstracts to support GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. Topics covered by the abstracts include basic and translational medicine, clinical research on cardiovascular diseases, cardiovascular-disciplinary research and cardiovascular prevention and rehabilitation.

For further information on GW-ICC and Asian Heart Society Congress 2021 please see the conference website: https://gwicc2021.sciconf.cn/en/web/index/1651

CVIA has just published the first issue of Volume 6

Highlighted papers in the issue are as follows:

Efficacy and Renal Tolerability of Ultrafiltration in Acute Decompensated Heart Failure: A Meta-analysis and Systematic Review of 19 Randomized Controlled Trials

By Yajie Liu and Xin Yuan (DOI 10.15212/CVIA.2021.0020).

In this important Review paper, the authors discuss, the importance of acute decompensated heart failure (ADHF) which is a life-threatening and costly disease. Controversy remains regarding the efficacy and renal tolerability of ultrafiltration for treating ADHF. The authors performed a meta-analysis to evaluate this clinical issue. A search of PubMed, EMBASE, and the Cochrane database of controlled trials was performed from inception to March 2021 for relevant randomized controlled trials. The quality of the included trials and outcomes was evaluated with the use of the risk of bias assessment tool and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, respectively. The risk ratio and the standardized mean difference (SMD) or weighted mean difference (WMD) were computed and pooled with fixed-effects or random-effects models. Results: This meta-analysis included 19 studies involving 1281 patients. Ultrafiltration was superior to the control treatments for weight loss (WMD 1.24 kg, 95% confidence interval [CI] 0.38–2.09 kg, P = 0.004) and fluid removal (WMD 1.55 L, 95% CI 0.51–2.59 l, P = 0.003) and was associated with a significant increase in serum creatinine level compared with the control treatments (SMD 0.15 mg/dL, 95% CI 0.00–0.30 mg/dL, P = 0.04). However, no significant effects were found for serum N-terminal prohormone of brain natriuretic peptide level, length of hospital stay, all-cause mortality, or all-cause rehospitalization in the ultrafiltration group. Conclusions: The use of ultrafiltration in patients with ADHF is superior to the use of the control treatments for weight loss and fluid removal but has adverse renal effects and lacks significant effects on long-term prognosis, indicating that this approach to decongestion in ADHF patients is efficient for fluid management but less safe renally.

Clinical Characteristics and Durations of Hospitalized Patients with COVID-19 in Beijing: A Retrospective Cohort Study

By Wen Zhao, Xiangyi Zha, Ning Wang, Dongzeng Li, Aixin Li and Shikai Yu (DOI 10.15212/CVIA.2021.0019)

In this important research paper, the authors provide information on clinical characteristics and different durations of COVID-19 and identify the potential risk factors for longer hospitalization of patients with COVID-19. In this retrospective study, the researchers enrolled 77 patients (age 52 ± 20 years; 44.2% males) with laboratory confirmed COVID-19 admitted to Beijing YouAn Hospital between January 21 and February 8, 2020. Epidemiological, clinical, and radiological data on admission were collected; complications and outcomes were followed up until February 26, 2020. The end point of the study was discharge alive within 2 weeks. Cox proportional-hazards regression was performed to identify risk factors for longer hospitalization. Results: Of 77 patients, there were 34 males (44.2%), 24 (31.2%) with comorbidities, 22 (28.6%) with lymphopenia, 20 (26.0%) with severe COVID-19, and 28 (36.4%) with complications. By the end of follow-up, 64 patients (83.1%) were discharged home, eight remained in hospital, and five had died. Thirty-six patients (46.8%) were discharged within 14 days and thus reached the study end point, including 34 of the 57 patients with nonsevere COVID-19 (59.6%) and two of the 20 patients with severe COVID-19 (10%). The overall cumulative probability of the end point was 48.3%. Hospital length of stay and the duration from exposure to discharge for the 64 discharged patients were 13 (10–16.5) days and 23 (18–24.5) days, respectively. A multivariable stepwise Cox regression model showed that bilateral pneumonia on CT scan, shorter time from illness onset to admission, severity of disease, and lymphopenia were independently associated with longer hospitalization. Conclusions: COVID-19 has a shorter duration of disease and hospital length of stay than severe acute respiratory syndrome. Bilateral pneumonia on CT scan, shorter period from illness onset to admission, lymphopenia, and severity of disease are the risk factors for longer hospitalization of patients with COVID-19.

CTO (Chronic Total Occlusion)

By Charles Richard Conti and Calvin Choi (DOI 10.15212/CVIA.2021.0015)

In this important Commentary paper, the authors consider the problem of CTO. There are no studies in patients with non-viable myocardium subtending a CTO to show improvement of regional wall motion after opening of the CTO. Patients without symptomatic multivessel CAD or no symptoms of angina have not been evaluated since there was no indication for study in the catheterization laboratory. CTO of collateral vessels that feed viable myocardium may lead to improvement in regional

myocardial wall motion and thus potentially a decrease in mortality. CTO recanalization in patients with active angina improve symptoms despite limited ability to demonstrate an improvement in wall motion.

31st GW-ICC Abstracts Publish in CVIA

31^st Great Wall International Cardiology Conference (GW-ICC) Abstracts Publish in Cardiovascular Innovations and Applications

Cardiovascular Innovations and Applications (CVIA), in its role as the official journal of the Great Wall International Cardiology Conference (GW-ICC), has published selected abstracts from the 31^st session, October 19 – 25, 2020, in its latest publication volume 5, supplement 1.

The abstracts are now available online at https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2019.0598

Co-Editors-in-Chief of CVIA Dr C. Richard Conti, past president of the American College of Cardiology, and Dr Jianzeng Dong, Capital Medical University, Beijing, China are delighted to be publishing the abstracts to support GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. Topics covered by the abstracts include basic and translational medicine, clinical research on cardiovascular diseases, cardiovascular-disciplinary research and cardiovascular prevention & rehabilitation.

Cardiovascular Innovations and Applications Now Indexed by EMBASE

We are pleased to announce that CVIA has been selected for indexing by EMBASE.

EMBASE is the most comprehensive international biomedical database for biomedical researchers. It enables tracking and retrieving of precise information on drugs and diseases from pre-clinical studies to searches on critical toxicological information from 1947 to the present day with 37.2 million+ records from almost 8,100 currently published journals. All articles are indexed in depth using Elsevier’s Life Science thesaurus Embase Indexing and Emtree®.

In addition to now being indexed by EMBASE, CVIA is also indexed in EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus.

30th GW-ICC Abstracts Publish in CVIA

30^th Great Wall International Cardiology Conference (GW-ICC) Abstracts Publish in Cardiovascular Innovations and Applications

Cardiovascular Innovations and Applications (CVIA), in its role as the official journal of the Great Wall International Cardiology Conference (GW-ICC), has published selected abstracts from the 30^th session, held in Beijing, China, October 10 – 13, 2019, in its latest publication volume 4, supplement 1.

The abstracts are now available online at https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2019.0021

Editor-in-Chief of CVIA Dr C. Richard Conti, past president of the American College of Cardiology, is delighted to be publishing the abstracts to support GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. Topics covered by the abstracts include basic and translational medicine, clinical research on cardiovascular diseases, cardiovascular-disciplinary research and cardiovascular prevention & rehabilitation.

For further information on GW-ICC please see the conference website: http://www.gw-icc2017.org/en/1/index.jsp

Newer Posts →